Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Elmariah, Hany, Salman Otoukesh, Ambuj Kumar, Haris Ali, Shukaib Arslan, Geoffrey Shouse, Hoda Pourhassan, et al. 2024. “Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis After Haploidentical Peripheral Blood Stem Cell Transplantation With Post-Transplantation Cyclophosphamide.”. Transplantation and Cellular Therapy 30 (2): 229.e1-229.e11.